<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=description content="Cancer patients have flocked from all over the world to a Houston oncologist who developed a cutting-edge treatment that achieves a complete remission in 50 percent of patients. Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex at his Salem Oncology Center."><meta name=author content="Larita Shotwell"><meta name=generator content="Hugo 0.98.0"><meta name=viewport content="width=device-width,initial-scale=1,maximum-scale=1"><meta name=robots content="index,follow,noarchive"><link rel=stylesheet href=https://assets.cdnweb.info/hugo/base16/css/style.css type=text/css><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Source+Code+Pro:400,700" type=text/css><link rel=alternate href=./index.xml type=application/rss+xml title=JadeVibe><title>Is this the world's best cancer doctor? Houston oncologist developed cutting-edge treatment for dise - JadeVibe</title></head><body><header><div class="container clearfix"><a class=path href=./index.html>[JadeVibe]</a>
<span class=caret># _</span><div class=right></div></div></header><div class=container><main role=main class=article><article class=single itemscope itemtype=http://schema.org/BlogPosting><div class=meta><span class=key>published on</span>
<span class=val><time itemprop=datePublished datetime=2024-06-02>June 02, 2024</time></span>
<span class=key>in</span>
<span class=val><a href=./categories/blog>blog</a></span></div><h1 class=headline itemprop=headline>Is this the world's best cancer doctor? Houston oncologist developed cutting-edge treatment for dise</h1><section class=body itemprop=articleBody><p class=mol-para-with-font><a style=font-weight:700 href=# id=mol-7d1de0f0-c2ea-11ee-9b7b-01ea6dc5195d>Cancer</a> patients have flocked from all over the world to a Houston oncologist who developed a cutting-edge treatment that achieves a complete remission in 50 percent of patients.</p><p class=mol-para-with-font>Philip Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex at his Salem Oncology Center.</p><p class=mol-para-with-font>'I have been in cancer medicine for 55 years. I have never seen before what I'm seeing now as a result of ICTriplex,' Salem told <a style=font-weight:700 class=class rel="nofollow noreferrer noopener" href=#>ABC7</a>.</p><p class=mol-para-with-font>The 82-year-old oncologist, at the forefront of cancer research, published his findings in <a style=font-weight:700 class=class rel="noreferrer noopener" href=#>the American Society of Clinical Oncology Journal</a> in June 2022.</p><p class=mol-para-with-font>The compelling outcomes of his study drew desperate patients from around the world, traveling thousands of miles to Houston, <a style=font-weight:700 href=# id=mol-7d242280-c2ea-11ee-9b7b-01ea6dc5195d>Texas</a>, in search of hope and the possibilities offered by this groundbreaking treatment.</p><img id=i-e70f61ea7e7429cd src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817709-13042315-image-a-6_1707002181170.jpg height=627 width=634 alt="Cancer patients have flocked from all over the world to a Houston oncologist,&nbsp;Philip Salem, who developed a cutting-edge treatment that sees 50 percent of patients achieve complete remission" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Cancer patients have flocked from all over the world to a Houston oncologist,&nbsp;Philip Salem, who developed a cutting-edge treatment that sees 50 percent of patients achieve complete remission</p><img id=i-1b257eead3ff806c src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817623-13042315-image-a-8_1707002195618.jpg height=357 width=634 alt="Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Salem, 82, combined immunotherapy, chemotherapy, and targeted therapy to create a breakthrough cancer treatment called ICTriplex</p><img id=i-5b6075310d189597 src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817627-13042315-image-a-7_1707002184902.jpg height=357 width=634 alt="Petra, a cancer patient who called the treatment to a miracle, said: 'I had a lot of pain in the beginning when I came here, and in the first month it was already gone'" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Petra, a cancer patient who called the treatment to a miracle, said: 'I had a lot of pain in the beginning when I came here, and in the first month it was already gone'</p><p class=mol-para-with-font>Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading.&nbsp;</p><p class=mol-para-with-font>'I did start therapy in Italy, but unfortunately the results of the therapy were not well, so I was in constant progression of the disease.'&nbsp;</p><p class=mol-para-with-font>Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said.</p><p class=mol-para-with-font>Petra, a cancer patient who called the treatment to a miracle, said: 'I had a lot of pain in the beginning when I came here, and in the first month it was already gone.'&nbsp;</p><p class=mol-para-with-font>Salem's oncology center is the only facility that uses the combination of immunotherapy, chemotherapy and targeted therapy in managing advanced cancer, the doctor said.&nbsp;</p><p class=mol-para-with-font>'We took patients who were told by major cancer centers to go home and die, and we produced 50 to 60 percent complete remission rate.'</p><p class=mol-para-with-font>'Zero percent against 50 percent, that's an easy choice,' cancer patient Marco Praagman said.&nbsp;</p><img id=i-a01bf531afce07ec src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817621-13042315-image-a-9_1707002353721.jpg height=357 width=634 alt="Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Bianca Gurrado, a patient who traveled from Italy to Houston, shared that she first learned about Dr. Salem around a year ago when her cancer was advancing and spreading</p><img id=i-792155ff630bca25 src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817625-13042315-image-a-10_1707002365920.jpg height=357 width=634 alt="Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Gurrado, who battled the challenging disease for three years, is now in a state of complete remission, Salem said</p><p class=mol-para-with-font>Salem's research on&nbsp;ICTriplex was published on the American Society of Clinical Oncology Journal, one of the most influential journals in the field.&nbsp;</p><p class=mol-para-with-font>He studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast,&nbsp;all of which were at an advanced stage of progression.</p><p class=mol-para-with-font>The total remission rate, considering patients in both partial remission and complete remission, was an impressive 90 percent.&nbsp;</p><p class=mol-para-with-font>In contrast, conventional treatments typically achieve a remission rate of less than 30 percent, he said.&nbsp;</p><p class=mol-para-with-font>He told <a style=font-weight:700 class=class rel="nofollow noreferrer noopener" href=#>Houston Chronicle</a> in 2022: 'And, to our surprise, this combination turns out to be very effective in a wide spectrum of cancer diagnoses. It does not limit it to one diagnosis or to one tumor.'&nbsp;</p><p class=mol-para-with-font>The groundbreaking treatment has been more effective in lung and pancreatic cancer patients, boasting a complete remission rate of 70 percent.&nbsp;</p><p class=mol-para-with-font>Salem said: 'We recommend the treatment as a front line, as the first line of therapy because it was very effective in the lung and the pancreas.'&nbsp;</p><img id=i-ebac41241f391e6e src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817633-13042315-image-a-11_1707002385819.jpg height=357 width=634 alt="'Zero percent against 50 percent, that's an easy choice,' cancer patient Marco Praagman said" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>'Zero percent against 50 percent, that's an easy choice,' cancer patient Marco Praagman said</p><img id=i-ded6b24981d524f5 src=https://cdn.statically.io/img/i.dailymail.co.uk/1s/2024/02/03/23/80817617-13042315-image-a-12_1707002422183.jpg height=357 width=634 alt="Salem studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast, all of which were at an advanced stage of progression" style=margin:auto;display:block;text-align:center;max-width:100%;height:auto><p class=imageCaption>Salem studied 41 patients with multiple types of cancer, including lung, pancreas, colorectal, breast, all of which were at an advanced stage of progression</p><p class=mol-para-with-font>Patients are grateful for Salem, acknowledging him as a beacon of hope as they battled with what is often considered the most difficult disease in the human world.&nbsp;</p><p class=mol-para-with-font>Ellie Moore, who was diagnosed with stage 4 lung cancer a decade ago, has been in remission since 2019.&nbsp;</p><p class=mol-para-with-font>'I knew that I had to do everything I could to fight and Dr. Salem assured me that we would not give up,' she said.&nbsp;</p><p class=mol-para-with-font>'Since I live in Houston, I was able to leave my office to receive treatment and could then return to work the same day,' she added.&nbsp;&nbsp;</p><p class=mol-para-with-font>'I love Dr. Salem; he's my hero,' said Gurrado with genuine happiness.&nbsp;&nbsp;</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7pa3IpbCmmZmhe6S7ja6iaKaVrMBwrdGtoJyklWJ%2BdHyTa2pqbV%2BXsrTAjJyYp5uVp3qlu8KtpqtleKTCtMDOp2SoppOkubCzyKyrZoiYnrmqvIyMmKWdnWKwsLnPpZytnV2nsq610qygqKZencGuuA%3D%3D</p></section></article></main></div><footer><div class=container><span class=copyright>&copy; 2024 JadeVibe - <a rel=license href=http://creativecommons.org/licenses/by/4.0/>CC BY 4.0</a></span></div></footer><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>